<H1>Chapter DOI: 10.1007/s00105-015-3653-6<br/>Cited-By Count: 1</H1><table border="1" width="30%"><tr><td>Total References</td><td>27</td></tr><tr><td>Springer references</td><td>7</td></tr><tr><td>Non Springer references</td><td>20</td></tr><tr><td>BibStructured Count</td><td width="10%">27</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>24</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Hunzelmann N (2013) Systemic scleroderma. Hautarzt 64(4):299&#8211;310</td><td><a href=http://dx.doi.org/10.1007/s00105-013-2537-x>10.1007/s00105-013-2537-x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Masi AT, Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581&#8211;590</td><td><a href=http://dx.doi.org/10.1002/art.1780230510>10.1002/art.1780230510</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202&#8211;205</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Aringer M, M&#252;ller-Ladner U, Burkhardt et al (2015) Gemeinsame deutschsprachige Nomenklatur f&#252;r die systemische Sklerose. Z Rheumatol 74(2):100&#8211;103</td><td><a href=http://dx.doi.org/10.1007/s00393-014-1550-5>10.1007/s00393-014-1550-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737&#8211;2747</td><td><a href=http://dx.doi.org/10.1002/art.38098>10.1002/art.38098</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Moinzadeh P, Aberer E, Ahmadi-Simab K et al (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 74(4):730&#8211;737</td><td><a href=http://dx.doi.org/10.1136/annrheumdis-2013-204487>10.1136/annrheumdis-2013-204487</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Hunzelmann N, Genth E, Krieg T et al (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology 47(8):1185&#8211;1192</td><td><a href=http://dx.doi.org/10.1093/rheumatology/ken179>10.1093/rheumatology/ken179</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Koenig M, Joyal F, Fritzler MJ et al (2008) Autoantibodies and Microvascular Damage Are Independent Predictive Factors for the Progression of Raynaud&#8217;s Phenomenon to Systemic Sclerosis. Arthritis Rheum 58(12):3902&#8211;3912</td><td><a href=http://dx.doi.org/10.1002/art.24038>10.1002/art.24038</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Czirj&#225;k L, Kum&#225;novics G, Varj&#250; C et al (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67(1):59&#8211;63</td><td><a href=http://dx.doi.org/10.1136/ard.2006.066340>10.1136/ard.2006.066340</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Moinzadeh P, Fonseca C, Hellmich et al (2014) Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma. Arthritis Res Ther 16(1):R53</td><td><a href=http://dx.doi.org/10.1186/ar4486>10.1186/ar4486</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Steen VD (2003) Scleroderma renal crisis. Rheum Dis Clin North Am 29(2):315&#8211;333</td><td><a href=http://dx.doi.org/10.1016/S0889-857X(03)00016-4>10.1016/S0889-857X(03)00016-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Mierau R, Moinzadeh P, Riemekasten G et al (2011) Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 13(5):R172</td><td><a href=http://dx.doi.org/10.1186/ar3495>10.1186/ar3495</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Kuwana M, Kaburaki J, Okana Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37(1):75&#8211;83</td><td><a href=http://dx.doi.org/10.1002/art.1780370111>10.1002/art.1780370111</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Hunzelmann N, Genth E, Krieg T et al (2008) Organ-specific diagnosis in patients with systemic sclerosis: recommendations of the German Network for Systemic Sclerosis (DNSS). Z Rheumatol 67(4):334&#8211;336</td><td><a href=http://dx.doi.org/10.1007/s00393-008-0291-8>10.1007/s00393-008-0291-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Scheja A, Akesson A (1997) Comparison of high frequency (20&nbsp;MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol 15(3):283&#8211;288</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Belz D, Hunzelmann N, Moinzadeh P (2014) Digital ulcers in systemic scleroderma. Hautarzt 65(11):944&#8211;948</td><td><a href=http://dx.doi.org/10.1007/s00105-014-3528-2>10.1007/s00105-014-3528-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Schlager O, Gschwandtner ME, Herberg et al (2010) Correlation of infrared thermography and skin perfusion in Raynaud patients and in healthy controls. Microvasc Res 80(1):54&#8211;57</td><td><a href=http://dx.doi.org/10.1016/j.mvr.2010.01.010>10.1016/j.mvr.2010.01.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Rossi D, Russo A, Manna E, et al (2013) The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev 12(8):821&#8211;825</td><td><a href=http://dx.doi.org/10.1016/j.autrev.2012.11.006>10.1016/j.autrev.2012.11.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Mimura Y, Ihn H, Jinnin M (2005) Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol 24(2):99&#8211;102</td><td><a href=http://dx.doi.org/10.1007/s10067-004-0975-7>10.1007/s10067-004-0975-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Latsi PI, Wells AU (2003) Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr Opin Rheumatol 15(6):748&#8211;755</td><td><a href=http://dx.doi.org/10.1097/00002281-200311000-00011>10.1097/00002281-200311000-00011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Proudman SM, Stevens WM, Sahhar J et al (2007) Pulmonary arteriel hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J 37(7):485&#8211;494</td><td><a href=http://dx.doi.org/10.1111/j.1445-5994.2007.01370.x>10.1111/j.1445-5994.2007.01370.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Khanna D, Nagaraja V, Gladue H et al (2013) Measuring response in the gastrointestinal tract in systemic sclerosis. Curr Opin Rheumatol 25(6):700&#8211;706</td><td><a href=http://dx.doi.org/10.1097/01.bor.0000434668.32150.e5>10.1097/01.bor.0000434668.32150.e5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Kaye SA, Lim SG, Taylor M et al (1995) Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 34(3):265</td><td><a href=http://dx.doi.org/10.1093/rheumatology/34.3.265>10.1093/rheumatology/34.3.265</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Champion HC (2008) The Heart in Scleroderma. Rheum Dis Clin North Am 34(1):181&#8211;190</td><td><a href=http://dx.doi.org/10.1016/j.rdc.2007.12.002>10.1016/j.rdc.2007.12.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Steen VD, Mayes MD, Merkel PA (2003) Assessment of kidney involvement. Clin Exp Rheumatol 21(3):S29&#8211;S31</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Domsic RT, Rodriguez-Reyna T, Lucas M et al (2011) Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 70(1):104&#8211;109</td><td><a href=http://dx.doi.org/10.1136/ard.2009.127621>10.1136/ard.2009.127621</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809&#8211;1815</td><td><a href=http://dx.doi.org/10.1136/ard.2009.114264>10.1136/ard.2009.114264</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>